Nanoglia will be one of the world's leading Nano Convergence research companies focusing on the development of therapeutic drugs for Glia-Neuronal interaction, Neuroinflammation & Neurodegenerative diseases.
Established 2019. 05
NAME: Dong Woon Kim, DVM, Ph.D.
Department of Anatomy & Cell Biology
Chungnam National University College of Medicine
Daejeon, 35015, Republic of Korea
1994 - 2000: D.V.M. in Seoul National University, College of Veterinary Medicine, Seoul, Korea
2000 – 2006: Ph.D. in Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea
ACADEMIC AND PROFESSIONAL APPOINTMENTS
2003 – 2006: Teaching Assistant,
Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea
2006 – Present: Full time instructor, Assistant Professor, Associate Professor, Professor
Department of Anatomy, Chungnam University College of Medicine, Daejeon, Korea
Scopus Author ID: 57204150578
ResearcherID: W-8254-2018 (http://www.researcherid.com/rid/W-8254-2018)
For CV, Click here